Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 EUR | 0.00% | -66.67% | -88.89% |
Mar. 06 | Oxurion Raises Additional Funds from Convertible Bonds Issue | MT |
Jan. 23 | Oxurion Seeks Healthcare Mergers Under New Corporate Strategy | MT |
Sales 2021 | 1.13M 1.23M | Sales 2022 | 595K 647K | Capitalization | 7.81M 8.49M |
---|---|---|---|---|---|
Net income 2021 | -29M -31.53M | Net income 2022 | -31M -33.7M | EV / Sales 2021 | 64.8 x |
Net Debt 2021 | 2.11M 2.3M | Net Debt 2022 | 4.42M 4.81M | EV / Sales 2022 | 20.6 x |
P/E ratio 2021 |
-2.39
x | P/E ratio 2022 |
-0.05
x | Employees | 20 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 56.31% |
1 week | -50.00% | ||
Current month | -50.00% | ||
1 month | -66.67% | ||
3 months | -88.89% | ||
6 months | -92.86% | ||
Current year | -88.89% |
Managers | Title | Age | Since |
---|---|---|---|
Ghoson Pascal
CEO | Chief Executive Officer | - | Dec. 27 |
Michael Dillen
SEC | Corporate Secretary | - | 20-02-29 |
Kathleen Paisley
LAW | General Counsel | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Anat Loewenstein
BRD | Director/Board Member | 64 | 23-03-13 |
James Hartmann
BRD | Director/Board Member | 58 | Dec. 27 |
Director/Board Member | - | 23-03-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 0.0001 | 0.00% | 32,327,010 |
24-03-15 | 0.0001 | -50.00% | 66,385,810 |
24-03-14 | 0.0002 | 0.00% | 35,641,820 |
24-03-13 | 0.0002 | +100.00% | 56,161,830 |
24-03-12 | 0.0001 | -66.67% | 82,931,440 |
Real-time Euronext Bruxelles, March 18, 2024 at 12:35 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-88.89% | 627K | |
+9.72% | 46B | |
+35.14% | 39.85B | |
+4.84% | 39.76B | |
-9.43% | 28.16B | |
+17.47% | 27.62B | |
-22.99% | 18.8B | |
+10.88% | 13.3B | |
+27.53% | 12.2B | |
-6.84% | 11.4B |